United States v. Jeremy P. Achey

943 F.3d 909
Court of Appeals for the Eleventh Circuit·Decided November 21, 2019·No. 18-11900·Published·Cited by 21 cases

Opinion

[PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

No. 18-11900

D.C. Docket No. 6:17-cr-00165-PGB-KRS-1

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus JEREMY ACHEY, Defendant-Appellant.

Appeal from the United States District Court for the Middle District of Florida

(November 21, 2019)

Before WILLIAM PRYOR and JILL PRYOR, Circuit Judges, and ROBRENO,* District Judge.

*

Honorable Eduardo C. Robreno, United States District Judge for the Eastern District of Pennsylvania, sitting by designation.

ROBRENO, District Judge:

Achey appeals his conviction for conspiracy to distribute a controlled substance, arguing that there was insufficient evidence to prove the existence of a conspiracy. This argument depends on a contention that the government was required to prove Achey conspired to distribute a specific controlled substance and at trial it only proved that Achey distributed a generic controlled substance. We disagree and hold that the government was only required to prove Achey conspired to distribute a generic controlled substance and that there was sufficient evidence to prove that multiple people conspired with Achey to distribute a generic controlled substance. We affirm.

I. BACKGROUND

Achey sold controlled substances on the dark web under the name EtiKing. On February 27, 2017, one of Achey’s customers died from an overdose involving an “analogue” of fentanyl, tetrahydrofuran fentanyl (“fentanyl”). The victim had acquired the drug that caused her death from EtiKing on the dark web. Following an investigation that included an undercover agent posing as a customer of EtiKing’s, Achey was arrested and charged with one count of conspiracy to distribute and possess with intent to distribute a controlled substance analogue1

1 We note that the indictment charged Achey with a conspiracy to distribute or possess with intent to distribute a generic controlled substance analogue, not a generic controlled substance. We assume for purposes of this appeal that the mens rea requirement to prove a conspiracy for a

and two counts of distributing a controlled substance analogue. The jury ultimately returned a conviction on all counts and determined that Achey had sold the drug that caused the victim’s death.2 The investigation revealed that various actors were involved in Achey’s drug operation. Achey purchased at least two types of fentanyl—methe fentanyl and tetrahydrofuran fentanyl—from “LS,” a company based in China. Specifically, he bought 50 grams of tetrahydrofuran fentanyl from LS. Others involved in the conspiracy included Achey’s wife, who delivered parcels of drugs to various post offices; a reseller of drugs, named “illianlikeavillian,” who sold smaller quantities of some of the drugs Achey sold him; and some repackagers who helped Achey ship out orders to customers.

Achey only challenges his conviction for conspiracy under Count One of the indictment. Count One charged:

[Defendant] did knowingly, willfully, and intentionally conspire with other persons, both known and unknown to the Grand Jury, to distribute and possess with intent to distribute a controlled substance analogue that was intended for human consumption,

generic controlled substance analogue is the same as for a conspiracy for a generic controlled substance. We make this assumption because Achey has not argued that the two crimes have different mens rea requirements, and there is no dispute in this case that the substances Achey conspired to distribute or possess with intent to distribute qualified as controlled substance analogues. 2 Achey was sentenced to life imprisonment, consisting of a term of life imprisonment on Count One, a term of life imprisonment on Count Two, and a term of 240 months’ imprisonment on Count Three, to be served concurrently.

which violation involved a mixture and substance containing a detectable amount of . . . (Tetrahydrofuran fentanyl)

Hydrochloride, a Schedule II controlled substance analogue, and a mixture and substance containing a detectable amount of . . . (4-ACO-DMT), a Schedule I controlled substance analogue, and is therefore punished under 21 U.S.C. § 84l(b)(l)(C).

Pursuant to 21 U.S.C. § 84l(b)(l)(C), on or about February 27, 2017, a person identified herein as “K.G.” died as a result of the use of a controlled substance analogue that the defendant conspired to distribute and possess with intent to distribute, that is, a mixture and substance containing a detectable amount of . . . (Tetrahydrofuran fentanyl) Hydrochloride, a Schedule II controlled substance analogue.

All in violation of 21 U.S.C. §§ 802(32), 813, and 846.

Achey challenges the sufficiency of the evidence to prove Count One on the basis that the government was required to prove that he conspired to distribute fentanyl or DMT, and it failed to prove a conspiracy as to the specific drug.

II. STANDARD OF REVIEW When reviewing a challenge to the sufficiency of the evidence, the evidence must be considered “in the light most favorable to the Government, drawing all reasonable inferences and credibility choices in the Government’s favor.” United States v. Browne, 505 F.3d 1229, 1253 (11th Cir. 2007). “If a

reasonable jury could conclude that the evidence establishes guilt beyond a reasonable doubt,” the verdict will be affirmed. Id.3 III. DISCUSSION

There was sufficient evidence to prove a conspiracy to distribute a controlled substance because Achey and at least one other person engaged in conduct from which an agreement to commit an illegal act can be inferred. The government was only required to prove a conspiracy to distribute a generic controlled substance because the indictment charged a conspiracy to distribute a controlled substance and not a conspiracy to distribute fentanyl or DMT. And in the light most favorable to the government, a reasonable jury could have found that Achey and at least one other person conspired to distribute a generic controlled substance.

A. The Government Was Required To Prove A Conspiracy To Distribute A Controlled Substance In General.

To convict Achey on Count One, the government was required to prove that he conspired to distribute a generic controlled substance. Achey argues otherwise, contending that here the indictment charged him with conspiracy to

3 The parties dispute whether the specific sufficiency of the evidence argument raised on appeal was made below. If an argument regarding the sufficiency of the evidence is not made below, and it is raised for the first time on appeal, we will apply plain error review to that argument on appeal. United States v. Joseph, 709 F.3d 1082, 1103 (11th Cir. 2013). Because the application of plain error review here does not change the outcome of the case, we need not decide this issue.

distribute fentanyl or DMT specifically and that therefore the government was required to prove there was an agreement to distribute fentanyl or DMT.

This argument fails. Achey misses an important distinction: proof of the type of drug involved in the conspiracy is separate and distinct from proof of mens rea as to the type of drug. The statutes under which Achey was indicted do not require proof of a conspiracy to distribute a specific controlled substance. A reference in the indictment to a specific controlled substance does not necessarily put the government to the burden of proving a conspiracy to distribute the specific controlled substance. And the government does not have the burden to prove a conspiracy to distribute the specific controlled substance when the reference to the specific controlled substance is fairly read to apply to the sentencing enhancement provision of the statute and not to the elements of the offense.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Jeremy P. Achey, 943 F.3d 909 (11th Cir. 2019).

943 F.3d 909 (United States v. Jeremy P. Achey) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Untitled Case
M.D. Florida, 2026
Untitled Case
M.D. Florida, 2026
United States v. Kermon Williams
Eleventh Circuit, 2026
United States v. Emiliya Radford
Eleventh Circuit, 2026
United States v. Johnnie Lott
Eleventh Circuit, 2025
United States v. Vincent Vo Tran
Eleventh Circuit, 2024
United States v. Raquan Emahl Gray
94 F.4th 1267 (Eleventh Circuit, 2024)
United States v. Avery Lans
Eleventh Circuit, 2024
United States v. Andres Mencia
Eleventh Circuit, 2022
United States v. David Lee Berry
Eleventh Circuit, 2022
Everton Daye v. U.S. Attorney General
38 F.4th 1355 (Eleventh Circuit, 2022)
United States v. Jonathan Bohn
Eleventh Circuit, 2022
United States v. Jerimiah Swanson
Eleventh Circuit, 2021
United States v. Laneesha Colston
4 F.4th 1179 (Eleventh Circuit, 2021)